ÐÇ¿Õ´«Ã½

Michelle Debbink
( out of 25 reviews )

Michelle Debbink, MD, PhD

Languages spoken: English

Clinical Locations

Redwood ÐÇ¿Õ´«Ã½ Center

Salt Lake City
801-213-9900

South Jordan ÐÇ¿Õ´«Ã½ Center

South Jordan
801-213-4500

South Main Clinic

Salt Lake City
801-587-2525

U of U ÐÇ¿Õ´«Ã½ Elko Specialty Clinic

Maternal Fetal Medicine Outreach Clinic
Elko
801-581-8425

  • Dr. Michelle Debbink considers it a privilege and honor to care for others during life-changing and vulnerable moments. As a maternal-fetal medicine specialist, she provides prenatal care for patients with high-risk or rare medical conditions, such as diabetes and congenital heart disease. She also specializes in abnormal placenta conditions like placenta previa and placenta accreta spectrum disorders, as well as fetal and genetic conditions, including twin and higher-order multiple pregnancies and anomalies.

    As a fellowship-trained specialist, Dr. Debbink provides services including vaginal and cesarean delivery, complicated cesarean delivery and cesarean hysterectomy, cervical cerclage, intrauterine transfusion (IUT), and percutaneous umbilical cord sampling (PUBS), and amniocentesis.

    Dr. Debbink is currently accepting new patients. To schedule an appointment or for more information, please call the Women’s ÐÇ¿Õ´«Ã½ Center at 801-213-2995.

    Dr. Debbink earned her bachelor’s degrees in sociology and health policy from Rice University in Houston, Texas. She received her medical degree from the University of Michigan Medical School, where she also completed her PhD in health services organization and policy along with her obstetrics and gynecology residency. In 2017, she moved to Salt Lake City to complete her fellowship in maternal-fetal medicine at the University of Utah. This means she has completed special training in the field of high-risk pregnancy.

    Her research focuses on racial, ethnic, and geographic inequities and disparities in perinatal outcomes, including low birth weight, small for gestational age, maternal morbidity, and maternal mortality. Dr. Debbink is particularly interested in how social structures, neighborhood factors, and health policy produce and reinforce perinatal health disparities among Black, Indigenous, and other people of color.

    Through research and practice, Dr. Debbink aims to collaborate on efforts to support resilient, strong communities for all pregnant and parenting folks and their families. She looks forward to building supportive, trusting relationships with patients across Utah.

    Outside of her medical practice and research, Dr. Debbink enjoys spending time with her family and dogs, reading, hiking, skiing, camping, stargazing, playing board games, and finding quiet moments near the water.

    Specialties

    Board Certification

    American Board of Obstetrics & Gynecology (Obstetrics & Gynecology)
    American Board of Obstetrics & Gynecology (Sub: Maternal-Fetal Medicine)

    Patient Rating

    5.0 /5
    ( out of 25 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    July 21, 2024
    REDWOOD HEALTH CENTER

    We absolutely LOVE Dr Debbink! We are so thankful to be in her care and trust her with our growing family. She has already gone above and beyond to ensure we feel at peace with the care we are receiving.

    December 28, 2023
    EXTERNAL SITE

    Dr Debbink is an awesome dr!!

    November 13, 2023
    REDWOOD HEALTH CENTER

    La mejor Ginecóloga súper buena persona y doctora explica todo perfecto , estoy súper agradecida con ella Dios la bendiga

    November 12, 2023
    REDWOOD HEALTH CENTER

    Dr. Debbink is very invested in my whole health! Each visit she has checked on my mental health and I really appreciate that. She literally saved my life and I could never be more appreciative of her surgical skills.

    May 10, 2023
    SOUTH JORDAN HEALTH CENTER

    She's so very caring, always makes sure I'm doing okay, makes sure I'm well taken care of.

    April 30, 2023
    REDWOOD HEALTH CENTER

    She is just wonderful all around. Very good at what she does. I know I'm in good hands. She is also very personable too, so we are able to joke and laugh too. She is the best doctor I've ever had.

    March 05, 2023
    REDWOOD HEALTH CENTER

    Dr. Debbink provided fabulous care and I felt like my concerns were heard and addressed.

    January 29, 2023
    REDWOOD HEALTH CENTER

    She is one of the best doctors I've ever had. I feel comfortable with her and confident that me and my baby are in good hands with her. And she has a fun personality too.

    January 11, 2023
    REDWOOD HEALTH CENTER

    Dr. Debbink is always kind and fun to talk to. She is very understanding and knowledgeable as well. I fully trust her judgement, but she also respects and asks for my opinions in decisions as well.

    See More Patient Comments

  • Dr. Michelle Debbink considers it a privilege and honor to care for others during life-changing and vulnerable moments. As a maternal-fetal medicine specialist, she provides prenatal care for patients with high-risk or rare medical conditions, such as diabetes and congenital heart disease. She also specializes in abnormal placenta conditions like placenta previa and placenta accreta spectrum disorders, as well as fetal and genetic conditions, including twin and higher-order multiple pregnancies and anomalies.

    As a fellowship-trained specialist, Dr. Debbink provides services including vaginal and cesarean delivery, complicated cesarean delivery and cesarean hysterectomy, cervical cerclage, intrauterine transfusion (IUT), and percutaneous umbilical cord sampling (PUBS), and amniocentesis.

    Dr. Debbink is currently accepting new patients. To schedule an appointment or for more information, please call the Women’s ÐÇ¿Õ´«Ã½ Center at 801-213-2995.

    Dr. Debbink earned her bachelor’s degrees in sociology and health policy from Rice University in Houston, Texas. She received her medical degree from the University of Michigan Medical School, where she also completed her PhD in health services organization and policy along with her obstetrics and gynecology residency. In 2017, she moved to Salt Lake City to complete her fellowship in maternal-fetal medicine at the University of Utah. This means she has completed special training in the field of high-risk pregnancy.

    Her research focuses on racial, ethnic, and geographic inequities and disparities in perinatal outcomes, including low birth weight, small for gestational age, maternal morbidity, and maternal mortality. Dr. Debbink is particularly interested in how social structures, neighborhood factors, and health policy produce and reinforce perinatal health disparities among Black, Indigenous, and other people of color.

    Through research and practice, Dr. Debbink aims to collaborate on efforts to support resilient, strong communities for all pregnant and parenting folks and their families. She looks forward to building supportive, trusting relationships with patients across Utah.

    Outside of her medical practice and research, Dr. Debbink enjoys spending time with her family and dogs, reading, hiking, skiing, camping, stargazing, playing board games, and finding quiet moments near the water.

    Board Certification and Academic Information

    Academic Departments Obstetrics & Gynecology -Primary
    Academic Divisions Maternal Fetal Medicine
    Board Certification
    American Board of Obstetrics & Gynecology (Obstetrics & Gynecology)
    American Board of Obstetrics & Gynecology (Sub: Maternal-Fetal Medicine)

    Education history

    Fellowship Maternal Fetal Medicine - University of Utah Clinical Fellow
    Chief Resident Obstetrics and Gynecology - University of Michigan ÐÇ¿Õ´«Ã½ System Administrative Chief Resident
    Residency Obstetrics and Gynecology - University of Michigan ÐÇ¿Õ´«Ã½ System Resident
    Doctoral Training ÐÇ¿Õ´«Ã½ Services Organization and Policy - University of Michigan School of Public ÐÇ¿Õ´«Ã½ Ph.D.
    Professional Medical Medical Scientist Training Program Fellow - University of Michigan Medical School M.D., Ph.D.
    Undergraduate Sociology, Policy Studies - Rice University B.A.

    Selected Publications

    Journal Article

    1. Bruno AM, Horns JJ, Allshouse AA, Metz TD, Debbink ML, Smid MC (2023). Association Between Periviable Delivery and New Onset of or Exacerbation of Existing Mental ÐÇ¿Õ´«Ã½ Disorders. Obstet Gynecol, 141(2), 395-402. ()
    2. Gartner DR, Debbink MP, Brooks JL, Margerison CE (2022). Inequalities in cesarean births between American Indian & Alaska Native people and White people. ÐÇ¿Õ´«Ã½ Serv Res. ()
    3. Scaglione MA, Allshouse AA, Canfield DR, Mclaughlin HD, Bruno AM, Hammad IA, Branch DW, Maurer KA, Dood RL, Debbink MP, Silver RM, Einerson BD (2022). Prophylactic Ureteral Stent Placement and Urinary Injury During Hysterectomy for Placenta Accreta Spectrum. Obstet Gynecol, 140(5), 806-811. ()
    4. Headen IE, Elovitz MA, Battarbee AN, Lo JO, Debbink MP (2022). Racism and perinatal health inequities research: where we have been and where we should go. Am J Obstet Gynecol, 227(4), 560-570. ()
    5. Carson BN, Schaeffer A, Burnam M, Brooks A, McCowan K, Johnson T, Debbink M, Goodman J, Hsu AL (2022). A Summary of Maternal Mortality in Missouri: A Historical Perspective (1999-2018). Mo Med, 119(5), 474-478. ()
    6. Kuramoto G, Hammad IA, Einerson BD, Allshouse AA, Debbink M, Grainger DW, Silver RM, Okano T (2020). Human Mesenchymal Stem Cell Sheets Improve Uterine Incision Repair in a Rodent Hysterotomy Model. Am J Perinatol, 39(11), 1212-1222. ()
    7. McLaughlin HD, Benson AE, Scaglione MA, Saviers-Steiger JS, Canfield DR, Debbink MP, Silver RM, Einerson BD (2022). Association between short interpregnancy interval and placenta accreta spectrum. AJOG Glob Rep, 2(2). ()
    8. Debbink MP, Metz TD, Nelson RE, Janes SE, Kroes A, Begaye LJ, Heuser CC, Smid MC, Silver RM, Varner MW, Einerson BD (2021). Directly Measured Costs of Severe Maternal Morbidity Events during Delivery Admission Compared with Uncomplicated Deliveries. Am J Perinatol, 39(6), 567-576. ()
    9. Givens M, Einerson BD, Allshouse AA, Bruno AM, Hammad I, Debbink MP, Branch DW, Silver RM (2021). Trends in Unplanned Peripartum Hysterectomy in the United States, 2009-2020. Obstet Gynecol, 139(3), 449-451. ()
    10. McLaughlin HD, Benson AE, Scaglione MA, Saviers-Steiger JS, Canfield DR, Debbink MP, Silver RM, Einerson BD (2022). Association between short interpregnancy interval and placenta accreta spectrum. AJOG Glob Rep, 2(2), 100051. ()
    11. Irani RAHolliman KDebbink MDay LMehlhaff KGill LHeuser CKachikis AStrickland KTureson JShank JPilliod RIyer CHan CS (2022). Complete Molar Pregnancies with a Coexisting Fetus: Pregnancy Outcomes and Review of Literature. AJP Rep, 12(1), E96-E107. ()
    12. Debbink MP, Ugwu LG, Grobman WA, Reddy UM, Tita ATN, El-Sayed YY, Wapner RJ, Rouse DJ, Saade GR, Thorp JM Jr, Chauhan SP, Costantine MM, Chien EK, Casey BM, Srinivas SK, Swamy GK, Simhan HN, Eunice Kennedy Shriver National Institute of Child ÐÇ¿Õ´«Ã½ and Human Development NICHD Maternal-Fetal Medicine Units MFMU Network (2021). Racial and Ethnic Inequities in Cesarean Birth and Maternal Morbidity in a Low-Risk, Nulliparous Cohort. Obstet Gynecol, 139(1), 73-82. ()
    13. Boelig RC, Aagaard KM, Debbink MP, Shamshirsaz AA (2021). Society for Maternal-Fetal Medicine Special Statement: COVID-19 research in pregnancy: progress and potential. Am J Obstet Gynecol, 225(6), B19-B31. ()
    14. Grobman WA, Crenshaw EG, Marsh DJ, McNeil RB, Pemberton VL, Haas DM, Debbink M, Mercer BM, Parry S, Reddy U, Saade G, Simhan H, Mukhtar F, Wing DA, Kershaw KN, NICHD nuMoM2b NHLBI nuMoM2b Heart ÐÇ¿Õ´«Ã½ Study Networks (2021). Associations of the Neighborhood Built Environment with Gestational Weight Gain. Am J Perinatol. ()
    15. Parchem JG, Rice MM, Grobman WA, Bailit JL, Wapner RJ, Debbink MP, Thorp JM Jr, Caritis SN, Prasad M, Tita ATN, Saade GR, Sorokin Y, Rouse DJ, Tolosa JE, Eunice Kennedy Shriver National Institute of Child ÐÇ¿Õ´«Ã½ Human Development Maternal-Fetal Medicine Units MFMU Network (2021). Racial and Ethnic Disparities in Adverse Perinatal Outcomes at Term. Am J Perinatol. ()
    16. Kershaw KN, Marsh DJ, Crenshaw EG, McNeil RB, Pemberton VL, Cordon SA, Haas DM, Debbink MP, Mercer BM, Parry S, Reddy U, Saade G, Simhan H, Wapner RJ, Wing DA, Grobman WA, NICHD nuMoM2b and NHLBI nuMoM2b Heart ÐÇ¿Õ´«Ã½ Study Networks (2021). Associations of the Neighborhood Built Environment With Physical Activity Across Pregnancy. J Phys Act ÐÇ¿Õ´«Ã½, 18(5), 541-547. ()
    17. Delaney RK, Locke A, Pershing ML, Geist C, Clouse E, Precourt Debbink M, Haaland B, Tanner AJ, Anzai Y, Fagerlin A (2021). Experiences of a ÐÇ¿Õ´«Ã½ System's Faculty, Staff, and Trainees' Career Development, Work Culture, and Childcare Needs During the COVID-19 Pandemic. JAMA Netw Open, 4(4), e213997. ()
    18. Swanson K, Debbink M, Letourneau JM, Kuppermann M, Einerson BD (2021). Association of multifetal gestation with obstetric and neonatal outcomes in gestational carrier pregnancies. J Assist Reprod Genet, 38(3), 661-667. ()
    19. Son SL, Allshouse AA, Page JM, Debbink MP, Pinar H, Reddy U, Gibbins KJ, Stoll BJ, Parker CB, Dudley DJ, Varner MW, Silver RM (2020). Stillbirth and fetal anomalies: secondary analysis of a case-control study. BJOG, 128(2), 252-258. ()
    20. Debbink MP, Son SL, Woodward PJ, Kennedy AM (2020). Sonographic Assessment of Fetal Growth Abnormalities. Radiographics, 41(1), 268-288. ()
    21. Smid MC, Maeda J, Stone NM, Sylvester H, Baksh L, Debbink MP, Varner MW, Metz TD (2020). Standardized Criteria for Review of Perinatal Suicides and Accidental Drug-Related Deaths. Obstet Gynecol, 136(4), 645-653. ()
    22. Premkumar A, Debbink MP, Silver RM, Haas DM, Simhan HN, Wing DA, Parry S, Mercer BM, Iams J, Reddy UM, Saade G, Grobman WA (2021). Association of Acculturation With Adverse Pregnancy Outcomes. Obstet Gynecol, 135(2), 301-309. ()
    23. Page JM, Bardsley T, Thorsten V, Allshouse AA, Varner MW, Debbink MP, Dudley DJ, Saade GR, Goldenberg RL, Stoll B, Hogue CJ, Bukowski R, Conway D, Reddy UM, Silver RM (2019). Stillbirth Associated With Infection in a Diverse U.S. Cohort. Obstet Gynecol, 134(6), 1187-1196. ()
    24. Smid MC, Stone NM, Baksh L, Debbink MP, Einerson BD, Varner MW, Gordon AJ, Clark EAS (2020). Pregnancy-Associated Death in Utah: Contribution of Drug-Induced Deaths. Obstet Gynecol, 133(6), 1131-1140. ()
    25. Martin LA, Hassinger JA, Debbink M, Harris LH (2017). Dangertalk: Voices of abortion providers. Soc Sci Med, 184, 75-83. ()
    26. Debbink MLP, Hassinger JA, Martin LA, Maniere E, Youatt E, Harris LH (2016). Experiences With the Providers Share Workshop Method: Abortion Worker Support and Research in Tandem. Qual ÐÇ¿Õ´«Ã½ Res, 26(13), 1823-1837. ()
    27. Martin LA, Debbink M, Hassinger J, Youatt E, Harris LH (2014). Abortion providers, stigma and professional quality of life. Contraception, 90(6), 581-7. ()
    28. Martin LA, Debbink M, Hassinger J, Youatt E, Eagen-Torkko M, Harris LH (2014). Measuring stigma among abortion providers: assessing the Abortion Provider Stigma Survey instrument. Women ÐÇ¿Õ´«Ã½, 54(7), 641-61. ()
    29. Clarke P, Morenoff J, Debbink M, Golberstein E, Elliott MR, Lantz PM (2014). Cumulative exposure to neighborhood context: consequences for health transitions over the adult life course. Res Aging, 36(1), 115-42. ()
    30. Payne CM, Debbink MP, Steele EA, Buck CT, Martin LA, Hassinger JA, Harris LH (2013). Why women are dying from unsafe abortion: narratives of Ghanaian abortion providers. Afr J Reprod ÐÇ¿Õ´«Ã½, 17(2), 118-28. ()
    31. Harris LH, Martin L, Debbink M, Hassinger J (2013). Physicians, abortion provision and the legitimacy paradox. Contraception, 87(1), 11-6. ()
    32. Harris LH, Debbink M, Martin L, Hassinger J (2011). Dynamics of stigma in abortion work: findings from a pilot study of the Providers Share Workshop. Soc Sci Med, 73(7), 1062-70. ()
    33. Debbink MP, Bader MD (2011). Racial residential segregation and low birth weight in Michigan's metropolitan areas. Am J Public ÐÇ¿Õ´«Ã½, 101(9), 1714-20. ()
    34. Martin LM, Debbink M, Hassinger JA, Harris LH (2011). Abortion, Possible and Impossible: Stigma and the Narratives of Ghanaian Doctors Who Provide Abortions. Reflections, 79-87.

    Review

    1. Brown O, Mou T, Tate M, Miller E, Debbink M (2022). Considerations for the Use of Race in Research in Obstetrics and Gynecology. [Review]. Clin Obstet Gynecol, 65(2), 236-243. ()
    2. Research Committee, Society for Maternal-Fetal Medicine SMFM, Boelig RC, Aagaard KM, Debbink MP, Shamshirsaz AA, SMFM Research Committee Electronic address smfmsmfmorg (2021). Society for Maternal-Fetal Medicine Special Statement: COVID-19 research in pregnancy: progress and potential. [Review]. Am J Obstet Gynecol, 225(6), B19-B31. ()

    Book

    1. Tarlov AR, Debbink MP (2008). Investing in early childhood development: Evidence to support a movement for educational change. ()

    Book Chapter

    1. Tarlov ARDebbink MP (2008). Preface. In Tarlov AR|Debbink MP (Ed.), Investing in Early Childhood Development: Evidence to Support a Movement for Educational Change (pp. xiii-xix). ()

    Abstract

    1. Debbink MP, Tanana H, Smid MC, Hardy C, Bloomquist K, Zickmund T, Galyean P, Zickmund S, Cochran G (2023). Barriers to implementation of substance use screening and treatment services for pregnant and postpartum individuals in a rural predominantly Native US county [Abstract]. 30(Supp 1), 134A-135A.
    2. Debbink MP, Tanana H, Perry R, Zapata D, Flake N, Metz TD (2023). US Urban Native Mothers’ Perspectives on Risk and Resiliency Factors for Maternal Morbidity [Abstract]. 30(Supp 1), 134A-135A.
    3. Monson MA, Masri J, Korst LM, Debbink MP, Llanes A, Chmait RH (2023). Disparities in fetal surgery access: Association with twin-twin transfusion syndrome stage at initial consultation [Abstract]. 228(1), S185--S186.
    4. Tiako MJN, Adesomo A, Zhang C, Kim J, Maxwell GL, Metz TD, Mbaidjol-Kabra R, Lutgendorf MA, Luo G, and Debbink MP (2023). Is racial segregation of hospital services associated with successful vaginal birth after cesarean? [Abstract]. American Journal of Obstetrics \& Gynecology, 228(1), S38--S39.
    5. Givens MB, Debbink MP, Theilen LH, Allshouse AA, Blue NR, Silver BM, Einerson BD (2023). Is placenta accreta spectrum inversely associated with hypertensive disorders of pregnancy? [Abstract]. 228(1), S537--S538.
    6. Smid, Marcela and Charron, Elizabeth and Allshouse, Amanda A and Campbell, Kristine and Debbink, Michelle P and Gordon, Adam G and Cochran, Gerald (2023). Trends in outpatient opioid prescriptions during pregnancy by clinician specialty in utah, 2014-2017 [Abstract]. 228(1), S693.
    7. Adesomo A, Tiako MJN, Zhang C, Kim J, Maxwell GL, Metz TD, Luo G, and Debbink MP (2023). Is racial segregation of hospital services associated with low-risk primary cesarean delivery? [Abstract]. 228(1), S588--S589.
    8. Smid M, Charron E, Debbink MP, Allshouse AA, Campbell K, Gordon AG, Cochran G (2023). Opioid prescriptions during pregnancy by race and ethnicity in Utah's urban and rural counties, 2014-2017 [Abstract]. 228(1), S692--S693.
    9. Dahl C, Turner A, Premkumar A, Bales C, Cheu L, Singh A, McCloskey L, Cowett A, Debbink MP (2023). Association between distance travelled for abortion care and abortion stigma [Abstract]. 228(1), S614-S615.
    10. Woodfield K, Baayd J, Debbink M, Harmer M, Kaiser J, Rothwell E, Tausinga T, Hayes K (2022). The premarital exam contextualized within adolescent sexual health [Abstract]. 35(2), 210.
    11. Woodfield K, Baayd J, Debbink M, Harmer M, Kaiser J, Rothwell E, Tausinga T, Hayes K (2022). Patient experiences with vaginal dilator therapy during premarital exams [Abstract]. 35(2), 210.
    12. Nourse SE, Begaye LJ, Shea A, Janes SE, Kroes A, Presson AP, Torre M, Heuser CC, Metz TD, Varner MW, Debbink MP (2022). Association of Iron Deficiency Anemia at Delivery and Insurance Type with Blood Transfusion [Abstract]. 29(SUPPL 1), 219--219.
    13. Smid MC, Allshouse AA, Campbell K, Debbink MP, and Cochran G (2022). Neonatal outcomes among pregnant individuals with co-occurring opioid/methamphetamine use disorders and mental health diagnosis [Abstract]. 226(1), S361--S362.
    14. Cummins H, Allshouse AA, Metz TD, Debbink MP (2022). Pilot non-inferiority study of group prenatal care versus standard care for pregnant people with diabetes [Abstract]. 226(1), S519.
    15. Debbink MP, Tavake-Pasi OF, Vaitohi ST, Flake N, Witte B, Varner MW, Metz TD (2022). Community risk and resilience for perinatal health among Native Hawaiian and Pacific Islander (NHPI) mothers [Abstract]. 226(1), S228--S229.
    16. Debbink MP, Tavake-Pasi OF, Vaitohi ST, Flake N, Witte B, Varner MW, Metz TD (2022). Native Hawaiian and Pacific Islander mothers' experiences with obstetric care providers and health systems [Abstract]. 226(1), S271-S272.
    17. Shea A, Debbink MP, Nourse SE, Kroes A, Janes S, Heuser CC, Varner MW, Metz TD (2021). Characteristics of Preventable Severe Maternal Morbidity. [Abstract]. 28(Supp 1), 144A-145A.
    18. Lauder JR, Debbink MP, Allshouse AA, Theilen LH, Haas DM, Simhan HN, Grobman WA, Yee LM, Chung JH, Mercer BM, et al (2021). Communication and Linguistic Barriers and Perinatal Outcomes Amongst Women with and without Diabetes [#22] [Abstract]. 224(2), S16.
    19. Smid MC, Allshouse AA, Campbell K, Debbink MP, Gordon AG, Kim J, Metz TD, Varner MW, Waitzman N, West N, et al (2021). Co-occurring opioid and methamphetamine use disorder and severe maternal morbidity and mortality in Utah [#639] [Abstract]. 224(2), S401-S402.
    20. Woodfield K, Hayes K, Sanders J, Debbink MP (2021). Association Between Religiosity, Erotophobia and Sexual Subjectivity in Members of The Church of Jesus Christ of Latter-day Saints [#92] [Abstract]. 34(2), 276.
    21. Debbink MP, McClurg AB (2020). Association of FQHC expansion with birth weight outcomes by race and neighborhood segregation [07C] [Abstract]. 135, 31s.
    22. Metz TD, Allshouse AA, Gnofam M, Debbink MP, Stickrath EH, Silver RM (2020). Marijuana Legalization in Colorado and Population-based Birth Outcomes. [Abstract]. 27(Supp 1), 287A.
    23. Page JM, Allshouse AA, Debbink MP, Simhan HN, Grobman WA, Reddy UM, Mercer BM, Wapner RJ, Chung JH, Saade GR, et al (2020). Gestational length variation at term by maternal race-ethnicity [#1206] [Abstract]. 222(1), S741-S742.
    24. Benson AE, Page JM, Debbink MP, Gibbins KJ, Varner MW, Monson M, Silver RM (2019). Characteristics of Stillbirth in Women with Hypertensive Disorders of Pregnancy: Stillbirth Collaborative Research Network Data. [Abstract]. 26(Supp 1), 359A.
    25. Page JM, Stoddard GJ, Debbink MP, Gibbins KJ, Silver RM (2019). Association of Race-Ethnicity and Placental Lesions in Stillbirth Cases. [Abstract]. 26(Supp 1), 167A-168A.
    26. Page JM, Debbink MP, Gibbins KJ, Varner MW, Silver RM (2019). Unexplained Stillbirth: Can Risk Factors Be Identified? [Abstract]. 26(Supp 1), 144A.
    27. Debbink MP, Premkumar A, Benson AE, Silver RM, Haas DM, Simhan HN, Wing D, Wadhwa PD, Parry S, Mercer BM, et al (2019). Association between acculturation and preterm birth is not mediated by measures of social stress [#290] [Abstract]. 220(1), S205-S206.
    28. Soffe K, Debbink MP, Theilen L, Silver RM, Wapner R, Grobman WA, Mercer BM, Saade G, Wing D (2019). Neonatal risks associated with maternal glucose intolerance in the absence of gestational diabetes [#397] [Abstract]. 220(1), S270-S271.
    29. Debbink MP, Wong J, Hollingshaus MS, Hanson HA, Carpenter JR, Varner MW, Smith KR (2019). Long term health after in utero exposure to the Geneva Steel Mill closure [#720] [Abstract]. 220(1), S474.

  • News & Podcasts

    News